Accelerate Diagnostics Inc EV/EBIT
What is the EV/EBIT of Accelerate Diagnostics Inc?
The EV/EBIT of Accelerate Diagnostics Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Accelerate Diagnostics Inc
What does Accelerate Diagnostics Inc do?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Companies with ev/ebit similar to Accelerate Diagnostics Inc
- Centogene NV has EV/EBIT of N/A
- Delek US Inc has EV/EBIT of N/A
- Freeport Resources has EV/EBIT of N/A
- AMMO has EV/EBIT of N/A
- AMMO has EV/EBIT of N/A
- Ultragenyx Pharmaceutical has EV/EBIT of N/A
- Accelerate Diagnostics Inc has EV/EBIT of N/A
- Eros International Plc has EV/EBIT of N/A
- Deveron UAS has EV/EBIT of N/A
- HT Media has EV/EBIT of N/A
- Aguila American Gold has EV/EBIT of N/A
- Sri Adhikari Brothers Television Network has EV/EBIT of N/A
- Zicom Electronic Security Systems has EV/EBIT of N/A